Doosan Group is in the final stage of negotiation for the sale of its Doosan Tower to Mastern Investment Management for roughly 700 billion won.
Doosan has been using the property, located at the Dongdaemun Shopping Complex in eastern Seoul, as the headquarters of its holding company for over two decades.
The group intends to lease Doosan Tower from Mastern after they complete the sale.
Doosan Tower is 34-story high and has seven basement levels, with 122,630 square-meter floor space.
Doosan Tower is on track to become the first asset to be sold by the group following the self-restructuring plan that was approved by its creditors, including the Korea Development Bank, in April.
Under the self-restructuring, Doosan Group needs to secure around 3 trillion won to salvage its key subsidiary Doosan Heavy Industries & Construction, in exchange for the creditors’ bailout.
Other assets of the group that may be up for sale are Doosan Solus and Doosan Fuel Cell.


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



